Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed drug fondaparinux; a new collaboration with... Read more
Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept... Read more
Singapore: Agilent Technologies extended its collaboration with the University of Sydney, Australia, by providing advanced analytical instrumentation to the university's... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in... Read more
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government to offer drugs at affordable... Read more
Singapore: AusBiotech is holding 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) in Sydney, Australia, for the first time ever.... Read more
Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and... Read more
Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product... Read more
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the mechanism by which it occurs... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
